A physiological role for cannabinoids in the CNS is indicated by the presence of endogenous cannabinoids and cannabinoid receptors. However, the cellular mechanisms of cannabinoid actions in the CNS have yet to be fully defined. In the current study, we identified a novel action of cannabinoids to enhance intracellular Ca 2ϩ responses in CNS neurons. 9 -Tetrahydrocannabinol (⌬ 9 -THC), the major psychoactive compound in marijuana (Cannabis sativa), is the prototypic agonist for the newly discovered class of cannabinoid receptors (Martin et al., 1994; Pertwee, 1997) . The CB1 subtype of cannabinoid receptors was cloned from the C NS (Matsuda et al., 1990) and found to be highly expressed in the cerebellum, hippocampus, and basal ganglia of the adult rat brain (Mailleux and Vanderhaeghen, 1992; Matsuda et al., 1993; Tsou et al., 1998) , a distribution consistent with many of the psychopharmacological actions of marijuana such as impaired memory, altered time perception, and loss of motor coordination (Adams and Martin, 1996) . Moreover, endogenous biochemicals such as N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol have been isolated from the C NS and found to reproduce many of the behavioral effects of ⌬ 9 -THC (Di Marzo, 1998). The presence of neuronal receptors and endogenous ligands indicates that an endogenous cannabinoid system for interneuronal communication exists in the C NS. However, the physiological role of this system and the cellular mechanisms of cannabinoid actions in the CNS have yet to be f ully elucidated.
A physiological role for cannabinoids in the CNS is indicated by the presence of endogenous cannabinoids and cannabinoid receptors. However, the cellular mechanisms of cannabinoid actions in the CNS have yet to be fully defined. In the current study, we identified a novel action of cannabinoids to enhance intracellular Ca 2ϩ responses in CNS neurons. Acute application of the cannabinoid receptor agonists R(ϩ)-methanandamide, R(ϩ)-WIN, and HU-210 (1-50 nM) dose-dependently enhanced the peak amplitude of the Ca 2ϩ response elicited by stimulation of the NMDA subtype of glutamate receptors (NMDARs) in cerebellar granule neurons. The cannabinoid effect was blocked by the cannabinoid receptor antagonist SR141716A and the G i /G o protein inhibitor pertussis toxin but was not mimicked by the inactive cannabinoid analog S(Ϫ)-WIN, indicating the involvement of cannabinoid receptors. In currentclamp studies neither R(ϩ)-WIN nor R(ϩ)-methanandamide altered the membrane response to NMDA or passive membrane properties of granule neurons, suggesting that NMDARs are not the primary sites of cannabinoid action. Additional Ca 2ϩ imaging studies showed that cannabinoid enhancement of the Ca 2ϩ signal to NMDA did not involve N-, P-, or L-type Ca 2ϩ channels but was dependent on Ca 2ϩ release from intracellular stores. Moreover, the phospholipase C inhibitor U-73122 and the inositol 1,4,5-trisphosphate (IP 3 ) receptor antagonist xestospongin C blocked the cannabinoid effect, suggesting that the cannabinoid enhancement of NMDA-evoked Ca 2ϩ signals results from enhanced release from IP 3 -sensitive Ca 2ϩ stores. These data suggest that the CNS cannabinoid system could serve a critical modulatory role in CNS neurons through the regulation of intracellular Ca 2ϩ signaling. Key words: cannabinoid; methanandamide; WIN; HU-210; cerebellum; granule neuron; NMDA; intracellular calcium ⌬ 9 -Tetrahydrocannabinol (⌬ 9 -THC), the major psychoactive compound in marijuana (Cannabis sativa), is the prototypic agonist for the newly discovered class of cannabinoid receptors (Martin et al., 1994; Pertwee, 1997) . The CB1 subtype of cannabinoid receptors was cloned from the C NS (Matsuda et al., 1990) and found to be highly expressed in the cerebellum, hippocampus, and basal ganglia of the adult rat brain (Mailleux and Vanderhaeghen, 1992; Matsuda et al., 1993; Tsou et al., 1998) , a distribution consistent with many of the psychopharmacological actions of marijuana such as impaired memory, altered time perception, and loss of motor coordination (Adams and Martin, 1996) . Moreover, endogenous biochemicals such as N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol have been isolated from the C NS and found to reproduce many of the behavioral effects of ⌬ 9 -THC (Di Marzo, 1998) . The presence of neuronal receptors and endogenous ligands indicates that an endogenous cannabinoid system for interneuronal communication exists in the C NS. However, the physiological role of this system and the cellular mechanisms of cannabinoid actions in the CNS have yet to be f ully elucidated.
Results from pharmacological studies suggest that cannabinoids produce many of their CNS effects by depressing Ca 2ϩ channel activity (Caulfield and Brown, 1992; Mackie and Hille, 1992; Felder et al., 1993; Mackie et al., 1995; Pan et al., 1996; Twitchell et al., 1997; Shen and Thayer, 1998) or enhancing K ϩ channel activity (Deadwyler et al., 1993; Henry and Chavkin, 1995; Mackie et al., 1995) . Consistent with actions on voltagesensitive Ca 2ϩ channels (VSCCs), cannabinoids reduce synaptically evoked intracellular Ca 2ϩ signals (Shen et al., 1996) and inhibit presynaptic glutamate release (Shen et al., 1996; Lévénès et al., 1998) . Cannabinoid effects on intracellular Ca 2ϩ signals such as occurs with inhibition of VSCCs could have important implications for other cellular functions, because Ca 2ϩ is an important intracellular second messenger. However, outside of inhibition of VSCCs, little is known about cannabinoid effects on neuronal Ca 2ϩ signaling pathways. An important pathway for Ca 2ϩ entry into CNS neurons is the NMDA subtype of glutamate receptors (NMDARs) (Mori and Mishina, 1995) . NMDARs play an important role in synaptic transmission and synaptic plasticity in the CNS, mediate trophic effects of glutamate in the developing nervous system, and help define many aspects of neuronal structure and function during the developmental program. Ca 2ϩ signaling is a critical component of these neuronal functions.
In the current study, we used fura-2 Ca 2ϩ imaging to examine the effects of cannabinoids on Ca 2ϩ signals elicited by stimulation of NMDARs in cultured cerebellar granule neurons. Ca 2ϩ signaling involving NMDARs is a complex cellular event involving numerous processes, including Ca 2ϩ influx through NMDARs and VSCCs and Ca 2ϩ release from intracellular stores (Simpson et al., 1995) . Our results show that cannabinoids enhance NMDA-evoked C a 2ϩ signals and that enhanced C a 2ϩ release appears to be the primary mechanism mediating this action of the cannabinoids. These results suggest that in addition to effects on ion channels, cannabinoid regulation of intracellular C a 2ϩ signaling may be an important mechanism through which cannabinoids modulate neuronal f unction in the C NS.
MATERIALS AND METHODS
Cerebellar cultures. Primary cultures of cerebellar granule neurons were prepared using a standard enzyme treatment protocol (Trenkner, 1991; Qiu et al., 1995) . Briefly, postnatal rat pups (8 d, Sprague Dawley; Charles River Laboratories, Wilmington, M A) were anesthetized with halothane, the were brains removed, and the cerebella were isolated. Tissue was dissociated in C a 2ϩ -and Mg 2ϩ -free saline containing trypsin (0.5%) and DNase I (2400 U/ml). The neurons were collected by centrif ugation and resuspended in DM EM and F-12 supplemented with 10% horse serum (heat-inactivated), 20 mM KC l, 30 mM glucose, 2 mM L-glutamine, and penicillin (20 U/ml)-streptomycin (20 g /ml). Neurons were plated at 1-4 ϫ 10 6 cells/ml onto Matrigel-coated cover glass (Fisher Scientific, Pittsburgh, PA; catalog #NC9351417) in tissue culture dishes. Cultures were incubated at 37°C in a humidified, 5% C O 2 atmosphere for up to 15 d. Serum-free medium (0.5 ml) was added every 7 d. Contamination by astrocytes was minimized by treatment with 5-fluoro-2Ј-deoxyuridine (20 g /ml) on the first and fourth days after plating.
Modified organotypic cultures of cerebellar neurons were prepared from the cerebella of embryonic day 20 rat pups and maintained in vitro as described previously (Gruol and Franklin, 1987) . In brief, cerebellar cortices were minced and triturated without enzymatic treatment in physiological saline and plated on cover glass coated with Matrigel. The plating medium contained minimal essential medium with Earle's salts and L-glutamine (M EM), 10% horse serum (heat-inactivated), 10% fetal calf serum (heat-inactivated) and 5.0 gm / l D-glucose. Brief treatment with 5-fluoro-2Ј-deoxyuridine (20 g /ml, days 4 -6 in vitro) minimized the growth of non-neuronal neurons. No antibiotics were used. Cultures were maintained at 37°C in a humidified, 5% C O 2 atmosphere.
Acutel y isolated cerebellar granule neurons. The method for preparing the acutely isolated granule neurons was similar to that used by Mermelstein et al. (1996) . Rat pups (5 d postnatal) were decapitated, and the cerebella were removed. Sagittal slices (350 -450 m) were prepared from the vermis in ice-cold oxygenated artificial C SF containing (in mM): 130 NaC l, 3.5 KC l, 1.25 NaH 2 PO 4 , 24 NaHC O 3 , 0.2 CaCl 2 , 5 MgSO 4 , and 10 glucose, pH 7.3. The white matter was removed, and the slices were minced in isethionate buffer containing 140 mM sodium isethionate, 2 mM KC l, 4 mM MgC l 2, , 23 mM glucose, 15 mM H EPES, 5 M glutathione, 1 mM N--nitro-L-arginine, and 10 mM kynurenic acid, pH 7.4 (room temperature). The tissue was incubated 45 min (at room temperature) in Earle's balanced salt solution supplemented with 5 M glutathione, 1 mM N--nitro-L-arginine, 10 mM kynurenic acid, and 1 mM pyruvate. The tissue was then incubated for 30 min (at 37°C) in 0.1% papain in HBSS supplemented with 5 M glutathione, 1 mM N--nitro-L-arginine, and 10 mM kynurenic acid. The tissue was washed three times in isethionate buffer and gently triturated. The neurons were plated on coated glass coverslips for experimental use.
Ca 2ϩ imag ing. Granule neurons 4 -15 d in vitro were used for experiments. Intracellular C a 2ϩ levels were measured in the somatic region of individual granule neurons using standard microscopic f ura-2 digital imaging techniques (Qiu et al., 1995) based on the methods of Grynkiewicz et al. (1985) . In brief, cells were incubated (30 min, room temperature) with the C a 2ϩ -sensitive dye f ura-2 AM (1.5 M) and pluronic F-127 (0.02%) in balanced salt solution (BSS) containing (in mM): 137 NaCl, 3.5 KCl, 0.4 KH 2 PO 4 , 0.33 Na 2 HPO 4 , 2.2 CaCl 2 , 2.0 MgSO 4 , 10 glucose, and 10 HEPES-NaOH, pH 7.3. The neurons were then incubated for 45 min in BSS to allow for cleavage of the AM from the fura-2 AM.
The cover glass with the granule neurons was mounted in a chamber attached to the stage of an inverted microscope equipped for phasecontrast and bright-field optics and f ura-2 video imaging. The cultures were bathed in Mg 2ϩ -free BSS containing glycine (5 M), a coagonist for NMDARs. Mg 2ϩ was omitted to relieve Mg 2ϩ -dependent block of the NMDAR (Mori and Mishina, 1995) . All recordings were made at room temperature (21-23°C).
Live video images of individual neurons were acquired at 3 sec intervals with a SI T-66 video camera (Dage -MTI, Michigan C ity, I N) at 340 and 380 nm and digitized for real-time display under the control of MicroComputer Imaging Device imaging software (Imaging Research Inc., St. C atharines, Ontario, C anada). Fluorescence ratios (340:380 nm) were converted to intracellular C a 2ϩ concentrations using the following formula:
where R is the ratio value, R min is the ratio for a C a 2ϩ -free solution, R max is the ratio for a saturated C a 2ϩ solution, K d ϭ 135 (the dissociation constant for f ura-2), F o is the intensity of a C a 2ϩ -free solution at 380 nm, and F s is the intensity of a saturated C a 2ϩ solution at 380 nm. C alibration was performed using f ura salt (100 M) in solutions of known C a 2ϩ concentration (Molecular Probes, Eugene, OR; kit C -3009). T ypical R max , R min , and F o /F s values were 0.61, 2.85, and 2.5, respectively. C ell calibration methods gave variable results and were not used. In the current study, the intracellular C a 2ϩ measurements are used to identif y relative changes in intracellular C a 2ϩ attributable to cannabinoid exposure and are not meant to provide information about absolute intracellular C a 2ϩ levels. Cellular autofluorescence and non-cell-associated background fluorescence (e.g., from the cover glass) were very low; therefore, background subtraction methods to correct for such fluorescence sources were not used.
E xperimental paradigm. Granule neurons were stimulated with NMDA, a selective agonist for NMDARs. NMDA was dissolved in the bath saline (i.e., BSS) and applied by brief microperf usion from glass micropipettes (1-3 m tip diameter) placed near the neurons of interest. The concentration (25-200 M) and duration (Յ1.0 sec) of NMDA application were adjusted under control conditions for each experiment to produce C a 2ϩ signals with a peak amplitude (50 -200 nM) that could be easily quantified. The cannabinoid receptor agonists produced similar actions regardless of the dose of NMDA used. Neurons were stimulated with 50 mM K ϩ in one group of experiments. For these studies, 50 mM KC l was substituted for an equivalent amount of NaC l in BSS and applied by micropipettes as described above. Fast green (0.003%) was included in NMDA and K ϩ solutions to monitor exposure of neurons to the test agent. Fast green by itself had no effect on neuronal firing, baseline C a 2ϩ levels, or the C a 2ϩ signal to NMDA. The time course of dye exposure indicated that the onset of neuronal exposure to the stimulant was relatively fast, occurring during the initial phase of the application period, whereas the clearance of the dye from the neuron (by diff usion) was slower, taking ϳ5-10 sec. Bath saline was exchanged between stimulations.
All pharmacological agents other than NMDA and K ϩ were applied to the cultures by bath replacement. Responses in the presence of cannabinoids were typically made 5-30 min after the initial cannabinoid exposure. C annabinoid receptor agonists and antagonists were prepared as stock (10 mM) solutions in DMSO or ethanol and diluted in BSS immediately before use. For the majority of experiments, the bath saline used during control recordings contained an amount of DMSO or ethanol equivalent to that used in the presence of cannabinoid agents. Separate vehicle control experiments showed that DMSO (Յ0.005%) or ethanol (Յ0.02 mM) did not affect the measurements under study.
T ypically, individual C a 2ϩ levels (resting and the response to NMDA) were measured simultaneously for 15-20 granule neurons within a microscopic field, with three to five microscopic fields measured per condition in each culture dish. Control and cannabinoid-treated neurons were recorded from the same culture dish, although each cell was tested under only one condition. Resting C a 2ϩ levels were subtracted from amplitude measurements (in response to NMDA) on an individual cell basis to yield peak C a 2ϩ values. Unless stated otherwise, results were normalized within a culture dish for better comparison of data obtained from different culture sets.
Electrophysiolog y. Parallel electrophysiological experiments were performed under conditions similar to those used for C a 2ϩ imaging (see above). Nystatin-patch recordings were made in the somatic region of granule neurons according to methods described previously (Netzeband et al., 1997) . Patch pipettes (4 -5 M⍀) were filled with a solution containing 6 mM NaC l, 154 mM K ϩ -gluconate, 2 mM MgC l 2 , 0.5 mM CaCl 2 , 10 mM H EPES-KOH, 10 mM glucose, 1 mM BAP TA, and 200 g /ml nystatin, pH 7.3. Stock solutions of nystatin (50 mg /ml DMSO) were prepared daily. Current-clamp recordings were made at the resting potential of the neuron under study using an Axopatch-1C amplifier (Axon Instruments, Foster C ity, CA). pCL AM P software and the Labmaster interface (Axon Instruments) were used for acquisition and analysis of current-evoked responses. All recordings were monitored on a polygraph and oscilloscope, and selected data were recorded on FM tape (Racal Recorders, Inc., Irvine, CA). Polygraph records were used for manual measurement of NMDA-evoked membrane responses.
Immunohistochemistr y. The CB1 receptor-specific antibody was gener-ously provided by Dr. Ken Mackie (University of Washington, Seattle, WA). The antibody has been characterized elsewhere (T witchell et al., 1997; Tsou et al., 1998) . CB1 immunostaining was performed with some modifications according to techniques reported previously (Gruol and Franklin, 1987 Additional chemicals were purchased from the following companies: fura-2 AM, pluronic F-127, and thapsigargin from Molecular Probes;
, and verapamil from Tocris Neuramin (Ballwin, MO); R(ϩ)- [2,3-dihydro-5-methyl-3-[(morpholinyl) [2,3-dihydro-5-methyl-3-[(4-morpholinyl) 
, pertussis toxin, Rp-adenosine 3Ј,5Ј-cyclic monophosphorothioate triethylamine (RpcAMPS), 9-(tetrahydro-2Ј-furyl)adenine (SQ 22536), and xestospongin C from Calbiochem (San Diego, CA); and -conotoxin GVIA from Peptides International (Louisville, KY) or Calbiochem.
was obtained courtesy of the National Institute on Drug Abuse (Rockville, MD). CGP55845A was a gift from Novartis (Basel, Switzerland). All other chemicals and drugs were purchased from Sigma (St. Louis, MO).
RESULTS

Cannabinoids dose-dependently enhance NMDAelicited intracellular Ca
2؉ signals Intracellular C a 2ϩ was measured in the somatic region of individual granule neurons at 4 -15 d in vitro (DIV). The granule neurons showed steady resting C a 2ϩ levels (see below) before NMDA application ( Fig. 1 A-C) . NMDA (25-200 M) was applied by brief microperf usion (Յ1 sec) and elicited a C a 2ϩ signal in these neurons characterized by an initial relatively rapid rise in intracellular C a 2ϩ to a peak amplitude of 50 -200 nM followed by a slower recovery to baseline C a 2ϩ levels ( Fig. 1 A-C) . Similar application of NMDA in electrophysiological experiments produced depolarizations of 10 -20 mV from resting membrane potentials of approximately Ϫ70 mV (see below). The peak amplitude of the NMDA-elicited Ca 2ϩ signal (minus the resting Ca 2ϩ level) was used as a relative measure of the size of the Ca 2ϩ response. The effect of cannabinoid receptor activation on NMDAelicited intracellular Ca 2ϩ signals was studied by bath application of cannabinoids. Three cannabinoid receptor agonists were tested: R(ϩ)-methanandamide (an unsaturated fatty acid ethanolamide and a metabolically stable analog of the presumed endogenous CB1 ligand anandamide; Abadji et al., 1994) , R(ϩ)-WIN (a cannabimimetic aminoalkylindole), and HU-210 (a tetrahydrocannabinol similar in structure to ⌬ 9 -THC). Different populations of neurons were used for the control and cannabinoid conditions. Each cannabinoid was tested on at least five different culture sets, and two doses of each cannabinoid were used. Only a single cannabinoid at one dose was tested per individual culture. Cannabinoid actions on NMDA-elicited intracellular Ca 2ϩ signals in the granule neurons were observed at all culture ages studied (4 -15 DIV). However, for the majority of experiments, 6 -8 DIV cultures were used.
R(ϩ)-Methanandamide (5 and 30 nM), R(ϩ)-WIN (5 and 20 nM), and HU-210 (1 and 5 nM) all enhanced the peak amplitude of the Ca 2ϩ signal to NMDA (Fig. 1 ). The extent of this enhancement showed some variation between culture sets, but the higher dose of each cannabinoid consistently produced a larger enhancement of the NMDA-evoked Ca 2ϩ signal than the lower dose, indicating that cannabinoid modulation was dosedependent. Cannabinoid enhancement of the Ca 2ϩ signal to NMDA was evident within 5-10 min of cannabinoid application (the earliest time point that data were obtained) and could be observed during the entire 30 min period used for data collection. However, after ϳ20 min of exposure the effectiveness of the cannabinoid started to decline, possibly because of desensitization (Howlett et al., 1991) , inactivation (Garcia et al., 1998) , or internalization (Hsieh et al., 1999) of the cannabinoid receptor. This aspect of cannabinoid action was noted but not studied further. The cannabinoids did not alter the general form of the Ca 2ϩ signal to NMDA ( Fig. 1 A- 
C).
Resting Ca 2ϩ levels in the granule neurons were fairly consistent within and between culture sets and typically ranged from 20 to 50 nM. These values are similar to resting Ca 2ϩ levels observed by others in cultured granule neurons (Courtney et al., 1990; Beani et al., 1994) . Although the cannabinoids produced small increases or decreases in resting Ca 2ϩ levels in individual cultures, there was no consistent effect between cultures. For example, in one set of experiments resting Ca 2ϩ levels averaged 45 Ϯ 4 nM under control conditions and 47 Ϯ 6 nM in the presence of 10 nM R(ϩ)-WIN ( p Ͼ 0.05, paired t test; six cultures).
In an additional set of control experiments, we determined whether alterations in synaptically driven events were responsible for the cannabinoid modulation of the NMDA-elicited Ca 2ϩ signals. Granule neurons are the only excitatory neurons intrinsic to the cerebellum and use glutamate as a neurotransmitter. The granule neurons constitute Ͼ95% of the neurons in culture, although a few GABA-containing neurons are present as well. Therefore, studies were performed in the presence of the AMPA and kainate receptor antagonist NBQX (5 M) and a GABA A receptor antagonist, either picrotoxin (100 M; two cultures) or bicuculline (30 M, three cultures), to block possible excitatory (glutamate) and inhibitory (GABA) inputs to the granule neurons. Results were comparable for studies using R(ϩ)-WIN (5-10 nM; three culture sets) or R(ϩ)-methanandamide (10 nM; two culture sets), so data were pooled. The mean peak amplitude of the C a 2ϩ signal to NMDA (25 or 50 M) was enhanced in the presence of the cannabinoid agonists to 160 Ϯ 2% of the control value ( p Ͻ 0.05, Mann -Whitney U test; n ϭ 356 neurons in control; n ϭ 299 neurons in cannabinoid; five culture sets). This increase was similar to that observed in the absence of receptor antagonists (see Fig. 1 ). These results indicate that an alteration in synaptic events is unlikely to account for the cannabinoid enhancement of NMDA-elicited C a 2ϩ signals. The granule neuron culture system has been extensively used as a model to investigate a variety of neuronal f unctions. However, questions could arise concerning the potential for the culture environment to alter granule neuron f unction. To address this issue, we tested the effects of R(ϩ)-W I N on the C a 2ϩ signal to NMDA in granule neurons acutely isolated from rat pups at 5 d postnatal, an age when cannabinoid receptors are known to be expressed in the cerebellum (Romero et al., 1997) . NMDA applied to the acutely isolated granule neurons in the same manner as for the cultured granule neurons elicited a C a 2ϩ signal that was comparable with that observed in the cultured granule neurons (Fig. 2 A) . Moreover, the C a 2ϩ signal to NMDA in the acutely isolated granule neurons was potentiated by R(ϩ)-WIN (Fig.  2 A) , consistent with results from the cultured granule neurons.
Another issue of concern is that the relative lack of normal target neurons for the cultured or acutely isolated granule neurons (e.g., Purkinje neurons) could alter the functional properties of the granule neurons. To address this issue, we tested the cannabinoid sensitivity of granule neurons in modified organotypic cultures of cerebellar neurons that contain all neuronal types present in the cortical region of the cerebellum in vivo and express synaptic connections between granule neurons and their target neurons (Gruol and Franklin, 1987) . The cultures were prepared from embryonic rat cerebellum and maintained in vitro for 3 weeks; the neurons are considered mature at this developmental age (Gruol and Franklin, 1987) . In these cultures, granule neurons responded to exogenously applied NMDA, whereas nearby Purkinje neurons did not (Fig. 2 B) , consistent with the known expression of NMDARs (Monyer et al., 1994) and sensitivity to exogenous NMDA (Garthwaite et al., 1987) in these neuronal types in vivo for the ages tested. Ca 2ϩ signals to NMDA in the granule neurons of the modified organotypic cultures were similar to that observed in the granule neuron cultures. Bath application of R(ϩ)-WIN enhanced the Ca 2ϩ signal to NMDA in the granule neurons in the organotypic cultures (Fig. 2 B) , as was observed for granule neurons in the granule neuron cultures. Taken together, these results indicate that cannabinoid enhance- 
-C, Effects of acute application of R(ϩ)-methanandamide ( A), R(ϩ)-WIN ( B), and HU-210 ( C) on the intracellular C a
2ϩ signals elicited by exogenous NMDA application. NMDA (50 or 200 M; see Materials and Methods) was applied at the arrows by a short (Յ1 sec) microperf usion pulse. Graphs depict averaged NMDA-elicited C a 2ϩ responses for individual fields of granule neurons under control conditions or in the presence of the specified concentration of cannabinoid agonist. Each trace represents the mean Ϯ SEM Ca 2ϩ response of 20 granule neurons measured individually in a microscopic field; error bars are smaller than the corresponding symbol in many cases. Different microscopic fields were used for each response, although all results for a particular cannabinoid are from the same culture set.
, and HU-210 ( F) on the peak amplitude of the intracellular Ca 2ϩ signals evoked by NMDA application. Numbers in each bar represent the total number of neurons measured; the values in parentheses indicate the number of culture sets used for each condition. In this and all other figures resting C a 2ϩ levels were subtracted from amplitude measurements on an individual cell basis. The peak amplitude of the C a 2ϩ response in each neuron was normalized to the mean peak control response for the culture and then data from different cultures combined. *Significant difference from control (
ment of the C a 2ϩ signal to NMDA represents a physiological response of granule neurons and not a response that is induced by the culture conditions.
Cannabinoid actions on NMDA-induced Ca 2؉ signals are mediated through a cannabinoid receptor
The observation that three structurally distinct cannabinoid receptor agonists [R(ϩ)-methanandamide, R(ϩ)-W I N, and HU-210] augment NMDA-elicited C a 2ϩ signals in a dose-dependent manner provides evidence that these effects are mediated through a cannabinoid receptor. To obtain additional support for receptor involvement in the cannabinoid modulation of NMDA-elicited Ca 2ϩ signals, we determined the stereoselectivity of R(ϩ)-WIN actions and tested the ability of the CB1 receptor antagonist SR141716A to block the cannabinoid actions.
In the first set of studies, the inactive cannabinoid enantiomer S(Ϫ)-W I N (5-20 nM) was tested on the NMDA-evoked Ca Cerebellar granule neurons in vivo express both mRNA (Mailleux and Vanderhaeghen, 1992) and protein (Tsou et al., 1998) for CB1, a receptor that has been characterized to couple negatively to adenylyl cyclase via G i /G o proteins (Martin et al., 1994) . We found that the CB1 phenotype is retained in culture as demonstrated by intense immunostaining of cultured granule neurons with an antibody to the CB1 receptor (Fig. 5) . Therefore, it was of interest to determine whether a G-protein was involved in the cannabinoid regulation of the NMDA-evoked C a 2ϩ signals in our studies.
Inactivation of G-proteins by pertussis toxin was used to test for the involvement of signal to NMDA, and these effects were blocked by SR141716A. Each response is from a different microscopic field and represents the mean Ϯ SEM C a 2ϩ signal for 20 granule neurons measured individually; error bars are smaller than the corresponding symbol in most cases. Data are from two different dishes from the same culture set; one culture was untreated, and the second culture was treated with SR141716A. B, Mean Ϯ SEM peak amplitudes of the NMDA-induced Ca 2ϩ signals elicited by all granule neurons studied in a single experiment. Individual responses were normalized as described in the legend for Figure 1 . Numbers in the bars represent the number of neurons measured for each condition. *Significant difference from control ( p Ͻ 0.05, Kruskal-Wallis test followed by post hoc analysis using Dunn's test). SR, SR141716A. Figure 5 . Granule neurons in culture express CB1 receptors. Photomicrographs are shown of granule neurons (12 DIV) immunostained with an antibody to the CB1 receptor and visualized using phase-contrast ( A) or bright-field ( B) optics. Antibody binding was detected using a peroxidase reaction and is seen best under Hoffman optics ( B). The majority of granule neuron somata were immunoreactive for CB1 receptors (arrows). However, a few granule neurons showed little or no CB1 receptor immunostaining (arrowheads). Only background levels of immunostaining were observed in the astrocyte layer underlying the granule neurons. Photomicrographs are of the same microscopic field.
cannabinoid. In contrast to the denatured toxin, the modulatory actions of R(ϩ)-W I N were completely blocked by active pertussis toxin. In pertussis toxin-treated cultures (two culture sets), the mean peak amplitude of the NMDA-elicited C a 2ϩ signal in the presence of R(ϩ)-W I N was 95 Ϯ 2% of the control value in pertussis toxin alone [p Ͼ 0.05, Mann -Whitney U test; n ϭ 187 neurons in control; n ϭ 186 neurons in R(ϩ)-W I N]. Treatment of cultures with pertussis toxin (100 ng /ml; 5 d) was also found to inhibit the actions of 20 nM R(ϩ)-methanandamide (data not shown). The overnight and 5 d treatments with pertussis toxin did not appear to alter the morphological features of the neurons or other aspects of the cultures. In addition, in electrophysiological experiments, pertussis toxin did not affect the amplitude of the membrane depolarization to NMDA (data not shown).
As a positive control for the effectiveness of pertussis toxin in blocking G i /G o , the membrane response of cerebellar granule neurons to the GABA B receptor agonist baclofen was tested under current-clamp conditions on cultures from the same culture sets used for the C a 2ϩ imaging studies. The GABA B receptor in these neurons is known to be coupled to potassium channel through a pertussis toxin-sensitive G i /G o protein (Slesinger et al., 1997) . Cultures were treated overnight with either active or denatured pertussis toxin (200 ng /ml). The response to baclofen (100 M; 1 sec application) was measured at a holding potential of Ϫ100 mV. Baclofen elicited a membrane depolarization of 5 Ϯ 1 mV (n ϭ 4 neurons) in neurons treated with denatured pertussis toxin. In contrast, the response to baclofen was completely abolished by active pertussis toxin (five of five neurons).
Cannabinoids do not alter membrane properties or the membrane response to NMDA
Cannabinoid receptor activation could enhance NMDAmediated C a 2ϩ signals in a number of ways. One mechanism would be to alter resting membrane potential or the input resistance of the neurons in such a way as to enhance C a 2ϩ influx mediated by NMDAR channels or VSCC s activated by the membrane depolarization to NMDA. To investigate this possibility, we used current-clamp recordings (nystatin perforated patch method) from the granule neurons to test the effects of cannabinoids on electrophysiological measures. There was no effect of R(ϩ)-methanandamide (30 nM) or R(ϩ)-WIN (30 nM) on resting membrane potential or input resistance of the granule neurons. Summarized results from these experiments are shown in Table  1 . These results suggest that the cannabinoid enhancement of NMDA-elicited Ca 2ϩ signals is not caused by changes in the passive membrane properties of the granule neurons.
Another mechanism by which cannabinoids could alter NMDA-elicited Ca 2ϩ signals would be to directly alter the function of NMDARs, perhaps through changes in the phosphorylation state of the NMDAR, such that the membrane depolarization is increased. To address this possibility, we measured the amplitude of the membrane depolarization to NMDA under control conditions or in the presence of R(ϩ)-methanandamide or R(ϩ)-WIN. The electrophysiological experiments were run in parallel with the Ca 2ϩ imaging studies. Under control conditions, NMDA (25 or 200 M; 1 sec application) elicited a rapid dosedependent membrane depolarization followed by a slow recovery to the resting membrane potential. Neither R(ϩ)-methanandamide (30 nM) nor R(ϩ)-WIN (20 -30 nM) altered the peak of the NMDA-induced depolarization (Fig. 7, Table 1 ). Higher concentrations of R(ϩ)-WIN (300 -500 nM) were also tested without significant effect on the peak of the NMDA-induced depolarization, resting membrane potential, or input resistance (data not shown).
Involvement of VSCCs and Ca
2؉ release from intracellular stores in cannabinoid augmentation of the Ca 2؉ signal to NMDA
The absence of a cannabinoid action on the NMDA-evoked membrane response suggests that cannabinoid modulation of intracellular Ca 2ϩ signal to NMDA is not attributable to effects of cannabinoids or cannabinoid receptor activation directed at the NMDAR itself. Activation of NMDARs in granule neurons increases intracellular Ca 2ϩ through several pathways, including Ca 2ϩ influx through NMDAR-channels, Ca 2ϩ influx through VSCCs activated by the membrane depolarization to NMDA, and Ca 2ϩ release from intracellular stores (Qiu et al., 1995; Qiu et al., 1998) . Thus, cannabinoids could influence the Ca 2ϩ signals to NMDA by actions on other pathways such as Ca 2ϩ influx through VSCCs activated by the membrane depolarization to NMDA or Ca 2ϩ release from intracellular stores. Several types of experiments were performed to determine whether these pathways contributed to the cannabinoid-induced enhancement of the Ca 2ϩ signal to NMDA. In the first series of experiments we examined the effect of cannabinoids on K ϩ depolarization, a stimulation paradigm known to evoke Ca 2ϩ influx through VSCCs and Ca 2ϩ -induced Ca 2ϩ release from intracellular stores in the cultured granule neurons (Qiu et al., 1995; Qiu et al., 1998) . Granule neurons were stimulated with 50 mM K ϩ (see Materials and Methods) to produce a Ca 2ϩ signal of similar magnitude to that produced by NMDA. In most experiments, antagonists for AMPA receptors influx. C annabinoids are known to inhibit VSCC s, and this regulation appears to be selective for the N-and P/Q-type Ca 2ϩ channels (Mackie and Hille, 1992; Pan et al., 1996; T witchell et al., 1997) . To determine whether cannabinoid-sensitive VSCCs are involved in cannabinoid enhancement of the Ca 2ϩ signal to NMDA, we tested the ability of the N-type Ca 2ϩ channel blocker -conotoxin GVIA (2 M) to block the effect of R(ϩ)-WIN on the Ca 2ϩ signal to NMDA. -Conotoxin GVIA produced a small depression of the Ca 2ϩ signal to NMDA under baseline control conditions (Fig. 9A) , consistent with our previous studies showing that VSCCs make a small contribution to the Ca 2ϩ signal to NMDA at the culture ages used for the cannabinoid studies (Qiu et al., 1998) . The presence of -conotoxin GVIA did not block the R(ϩ)-WIN enhancement of the Ca 2ϩ signal to NMDA, indicating that N-type VSCCs were not involved in the effect of R(ϩ)-WIN on the Ca 2ϩ signal to NMDA (Fig. 9A) . Similar results were obtained with the P-type Ca 2ϩ channel blocker -agatoxin IVA (Fig. 9B ) and the L-type Ca 2ϩ channel blockers verapamil (Fig. 9C) There was no difference between the control and cannabinoid groups for any of the parameters measured (p Ͼ 0.05, unpaired t test). Rin-hyperpol and Rin-depol are the input resistance calculated for the cells for membrane potentials hyperpolarized (Rin-hyperpol) or depolarized (Rin-depol) to resting membrane potential. Values for input resistance are taken from the slopes of input-output curves of the sustained voltage responses elicited by constant current (500 msec duration) hyperpolarizing (Rin-hyperpol) or depolarizing (Rin-depol) current injections. For Rin-depol, input resistance was determined only over the membrane potential range at which NMDA-elicited responses were observed (i.e., resting membrane potential to approximately Ϫ40 mV). release from intracellular stores to the Ca 2ϩ signal to NMDA (Fig. 10 A) release (Simpson et al., 1995) . Treatment of the granule neurons with dantrolene (10 M, 30 min) reduced the peak amplitude of the C a 2ϩ signal to NMDA (Fig. 10 B) , as was observed for caffeine ( Fig. 10 A) . However, dantrolene did not block the R(ϩ)-WIN-induced enhancement of the C a 2ϩ signal to NMDA (Fig.  10 B) , suggesting that stores controlled by the ryanodine receptor are not involved in cannabinoid regulation of the C a 2ϩ signal to NMDA. Thapsigargin is a C a 2ϩ -ATPase inhibitor (Simpson et al., 1995) and will prevent C a 2ϩ uptake into stores. If the stores are leaky, thapsigargin treatment will result in depletion of Ca 2ϩ from the stores. Treatment of the granule neurons with thapsigargin (1 M, 30 min) did not alter the peak amplitude of the Ca 2ϩ signal to NMDA. However, thapsigargin blocked the R(ϩ)-WIN-mediated enhancement of the C a 2ϩ signal to NMDA and revealed a cannabinoid-induced inhibition (Fig. 10C) (Fig. 11 A) , supporting the involvement of IP 3 -gated Ca 2ϩ stores in the cannabinoid modulation. Ca 2ϩ release from I P 3 -gated stores is commonly associated with G q -coupled receptors that activate phosphatidylinositolspecific phospholipase C, an enzyme that hydrolyzes phosphatidylinositol 4,5-bisphosphate into IP 3 and diacylglycerol. Although cannabinoid receptors are not known to be coupled to G q , the ␤␥ subunit of G i /G o can activate phospholipase C (Exton, 1996) , providing a pathway by which cannabinoids could modulate Ca 2ϩ release from IP 3 -gated Ca 2ϩ stores in the granule neurons. To evaluate this possibility, we tested the effect of the phospholipase C inhibitor U-73122 on the cannabinoid enhancement of the Ca 2ϩ signal to NMDA. Bath application of U-73122 (1-2 M) blocked the action of R(ϩ)-WIN on the Ca 2ϩ signal to NMDA, whereas the inactive analog U-73343 (1-2 M) was without effect (Fig. 11 B) , indicating that the phospholipase C transduction pathway is involved in the cannabinoid enhancement of Ca 2ϩ signals. Together, the ability of both U-73122 and xestospongin C to block the cannabinoid enhancement of NMDAevoked Ca 2ϩ signals indicates the involvement of the phospholipase C-IP 3 transduction pathway in this modulatory action of the cannabinoids.
We also examined whether the adenylyl cyclase-cAMP-protein kinase A signal cascade downstream from G i /G o was involved in mediating the cannabinoid enhancement of intracellular Ca 2ϩ signals, because cannabinoids are known to inhibit this transduction pathway through a pertussis toxin-sensitive G i /G o protein (Martin et al., 1994; Pertwee, 1997) . To address this question, we tested several agents known to act on components of the adenylyl cyclase cascade on the R(ϩ)-WIN (10 M) enhancement of the Ca 2ϩ signal to NMDA. In the first series of experiments, we examined agents that inhibit steps in the adenylyl cyclase cascade. Pre-exposure of the neurons to either the adenylyl cyclase inhibitor SQ 22536 (200 M; Fig. 11C NMDA-evoked C a 2ϩ signal. Thus, in contrast to our findings with the phospholipase C antagonist, pharmacological agents that interact with the adenylyl cyclase cascade did not block the cannabinoid enhancement of NMDA-evoked C a 2ϩ signals.
DISCUSSION
In these studies, we identified a novel action of cannabinoids in CNS neurons, namely that acute exposure to cannabinoid receptor agonists enhances the intracellular C a 2ϩ signal produced by NMDA in cultured cerebellar granule neurons. A similar effect of cannabinoids was observed in acutely dissociated cerebellar granule neurons. This action of cannabinoids appears to be mediated through the brain cannabinoid receptor (CB1) for several reasons. First, the effects on the NMDA-mediated C a 2ϩ signal were produced by nanomolar concentrations and in a dose-dependent manner by three chemically distinct cannabinoids: R(ϩ)-methanandamide, R(ϩ)-W I N, and HU-210. In addition, the cannabinoid effects were stereoselective for R(ϩ)-W I N versus the inactive analog S(Ϫ)-W I N, and the cannabinoid actions were blocked by the selective CB1 receptor antagonist SR141716A. Moreover, the block of cannabinoid action by the G i /G o inhibitor pertussis toxin f urther indicates the involvement of a cannabinoid receptor as has been described for other actions of cannabinoids (Pertwee, 1997) .
Activation of NMDARs in granule neurons increases intracellular C a 2ϩ through several pathways including C a 2ϩ influx through NMDAR channels, C a 2ϩ influx through VSCCs activated by the membrane depolarization to NMDA, and Ca 2ϩ release from intracellular stores (Qiu et al., 1995; Qiu et al., 1998) . Thus, cannabinoid enhancement of the C a 2ϩ signal to NMDA could result from cannabinoid modulation of one or more of these sites. However, our data suggest that the cannabinoid effect does not involve actions on NMDARs. First, the cannabinoids did not alter the membrane depolarization to NMDA in electrophysiological studies. Moreover, the cannabinoids augmented the Ca 2ϩ signals elicited by K ϩ stimulation, indicating that the cannabinoid enhancement of C a 2ϩ signals is independent of NMDA receptor activation. In addition, it appears unlikely that VSCCs are involved in the cannabinoid effect. All studies to date have shown that cannabinoids reduce C a 2ϩ currents (C aulfield and Brown, 1992; Mackie and Hille, 1992; Felder et al., 1993; Mackie et al., 1995; Pan et al., 1996; T witchell et al., 1997; Shen and Thayer, 1998) , an effect that would be expected to reduce C a 2ϩ signals. Our current demonstration that N-, P-, and L -type C a 2ϩ channel antagonists did not prevent the cannabinoid enhancement of NMDA-evoked C a 2ϩ signals provides f urther evidence that Ca 2ϩ channels do not play a prominent role in this action of cannabinoids.
In contrast to the above findings, caffeine and thapsigargin blocked the cannabinoid enhancement of the NMDA-evoked Ca 2ϩ signal, suggesting that C a 2ϩ release from intracellular stores contributes to the cannabinoid effect. C NS neurons typically express two types of intracellular C a 2ϩ stores, those gated by ryanodine receptors and those gated by I P 3 receptors (Simpson et al., 1995) . We found that the cannabinoid enhancement of NMDA-evoked C a 2ϩ signals was blocked in the presence of the IP 3 receptor antagonist xestospongin C, whereas the cannabinoid modulation was unaffected by the ryanodine receptor antagonist dantrolene. Furthermore, we found that the phospholipase C inhibitor U-73122 blocked the cannabinoid enhancement of the Ca 2ϩ signals to NMDA. Activation of phospholipase C generates the intracellular messenger I P 3 leading to C a 2ϩ release from IP 3 -gated Ca 2ϩ stores (Bezprozvanny and Ehrlich, 1995 stores in DDT 1 MF-2 smooth muscle cells (Filipeanu et al., 1997) , a cell type that does not express VSCCs. In those studies, the cannabinoid effect on Ca 2ϩ release was sensitive to blockade by SR141716A, indicating the involvement of the CB1 receptor. In another group of studies, the CB1 receptor ligands R(ϩ)-WIN, 2-arachidonoylglycerol, ⌬ 9 -THC, and anandamide induced elevations in intracellular Ca 2ϩ in neuroblastoma (NG108 -15) cells via an SR141716A-sensitive cannabinoid receptor (Sugiura et al., 1996 (Sugiura et al., , 1997 , an effect that was partially attributable to release of Ca 2ϩ from stores (Sugiura et al., 1996) . Interestingly, the cannabinoid-evoked Ca 2ϩ signals in the neuroblastoma cells were also sensitive to blockade by the phospholipase C inhibitor U-73122 (Sugiura et al., 1997) , suggesting that the cannabinoid effect involved IP 3 -gated Ca 2ϩ stores as observed in our studies. Release of Ca 2ϩ from IP 3 -regulated stores is known to be modulated by intracellular Ca 2ϩ levels (Bezprozvanny and Ehrlich, 1995) . Thus, Ca 2ϩ influx through NMDARs or VSCCs activated by membrane depolarization could interact with cannabinoid regulation of IP 3 -controlled Ca 2ϩ stores, resulting in greater Ca 2ϩ release during NMDA or K ϩ stimulations. A large number of in vitro studies have shown that cannabinoids inhibit basal, forskolin-stimulated, or hormone-stimulated cAMP accumulation in brain membrane preparations, cultured neurons, and cell lines expressing the CB1 receptor (Martin et al., 1994; Pertwee, 1997) . In general, these actions of the cannabinoids are sensitive to blockade by pertussis toxin, suggesting that cannabinoid receptors couple to G i /G o . In cerebellar membranes prepared from rat whole cerebellum or cultured granule neurons, several cannabinoids have been found to inhibit adenylyl cyclase activity, GTPase activity, and basal and forskolin-stimulated cAMP accumulation in a pertussis toxin-sensitive manner (Pacheco et al., 1991 (Pacheco et al., , 1994 Childers et al., 1994) . Our finding that cannabinoid enhancement of NMDA-elicited Ca 2ϩ signals is blocked by pertussis toxin is consistent with this mode of action. However, pharmacological agents that interact with the adenylyl cyclase transduction pathway did not block the cannabinoid effect in our studies. In fact, our studies suggest the involvement of phospholipase C, a pathway typically associated with G q (Exton, 1996) . This apparent discrepancy may reflect activation of phospholipase C through an alternative pathway.
Studies performed in expression systems have shown that ␤␥ subunits of G i /G o proteins activate phospholipase C (Exton, 1996) , suggesting that G i /G o -coupled receptors such as the cannabinoid receptors could enhance Ca 2ϩ release from IP 3 -gated Ca 2ϩ stores by stimulating the production of IP 3 by phospholipase C. Other G i /G o -protein-coupled receptors have been shown to induce intracellular Ca 2ϩ release from IP 3 -gated Ca 2ϩ stores. Most notably, opiate-evoked increases in intracellular Ca 2ϩ in NG108-15 cells are sensitive to blockade by the phospholipase C inhibitor U-73122 and depletion of intracellular Ca 2ϩ stores with thapsigargin (Jin et al., 1994) . In a recent study, Hampson et al. (1998) found that ⌬ 9 -THC and anandamide (0.1-1 M) depressed NMDA-elicited Ca 2ϩ signals measured spectrophotometrically in rat brain cerebellar and cortical slices. This cannabinoid action was attributed to decreased P-type C a 2ϩ channel activity via cannabinoid receptor activation because the effects were blocked by SR141716A, pertussis toxin, and the P-type C a 2ϩ channel antagonist -agatoxin IVA. In another study, CB1 receptor ligands [C P55,940, R(ϩ)-WIN, anandamide] were reported to reduce C a 2ϩ signals evoked by bath application of K ϩ in cultured granule neurons studied with microfluorimetry, an effect also attributed to cannabinoid regulation of VSCC s (Nogueron et al., 1998) . These results are in agreement with studies showing that cannabinoids inhibit N-and P-type Ca 2ϩ currents (C aulfield and Brown, 1992; Mackie and Hille, 1992; Felder et al., 1993; Mackie et al., 1995; Pan et al., 1996; T witchell et al., 1997; Shen and Thayer, 1998) . These inhibitory effects were not evident in our studies under normal conditions, perhaps because of a stronger contribution of Ca 2ϩ release from intracellular stores to the C a 2ϩ signal to NMDA and K ϩ under the conditions of our experiments in which the stimulants were applied only briefly. In contrast, in studies in which a depressive action of cannabinoids was observed, longerduration bath application of the NMDA and K ϩ was used (Hampson et al., 1998; Nogueron et al., 1998) .
Although the inhibitory effect of cannabinoids on intracellular Ca 2ϩ levels was not evident in our studies under normal conditions, a cannabinoid depression of NMDA-evoked C a 2ϩ signals was unmasked under conditions in which the cannabinoid enhancement of NMDA-evoked C a 2ϩ signals was blocked (e.g., in the presence of thapsigargin, U-73122, or xestospongin C). Thus, cannabinoids may increase or decrease intracellular C a 2ϩ levels depending on the physiological conditions. For example, the inhibitory effects of cannabinoids on C a 2ϩ signaling may be more prominent under conditions of strong stimulation that result in a high level of VSCC activity. In contrast, cannabinoid enhancement of C a 2ϩ release from stores may be more evident during periods of low stimulation, during which C a 2ϩ release from stores may make a larger contribution than VSCC s to the overall Ca 2ϩ signal. In addition, our results may be more applicable to the young developmental age of the neurons used in our studies or to regulatory mechanisms involved in the control of somatic Ca 2ϩ signaling. Interestingly, cannabinoids do not regulate L-type Ca 2ϩ channels, a VSCC type that is prominent in the somatic region of C NS neurons (Hell et al., 1993) , the cellular region measured in our studies.
Taken together, our studies show that intracellular Ca 2ϩ signaling is another important neuronal f unction that is regulated by cannabinoids. C a 2ϩ is an important intracellular second messenger that controls the activity of numerous enzymes (e.g., protein kinase C, M AP kinase, C a 2ϩ /calmodulin-dependent kinase) important for a variety of cellular processes, including growth and gene transcription. Thus, our data f urther support a neuromodulatory role of the endogenous cannabinoid system in CNS neuronal f unction.
